Predictors of high yield and purify of CD34⁺ cell-selected PBPC, collected from patients with multipe myeloma

Author： Webb I J Scholssman R L Jiroutek M Doss D Cohen C A Freeman A Schott D M Anderson K C

ISSN： 1465-3249

Source： Cytotherapy, Vol.1, Iss.3, 1999-01, pp. : 175-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD34⁺ cell enrichment depletes atypical CD30⁺ cells from PBPC grafts in patients with HD

By Blystad AK Torlakovic E Holte H Kvaløy S Lenschow E Kvalheim G

Cytotherapy, Vol. 3, Iss. 4, 2001-07 ,pp. : 295-305

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Impaired PBPC collection in patients with myeloma after high-dose melphalan

By Jansen J Thompson JM Dugan MJ Wiemann MC Hanks S Greenspan AR Akard LP

Cytotherapy, Vol. 6, Iss. 5, 2004-10 ,pp. : 498-504

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A preliminary analysis of the balance between Th1 and Th2 cells after CD34 + cell-selected autologous PBSC transplantation

By Endo T Sato N Koizumi K Nishio M Fujimoto K Yamamoto S Sakai T Bohgaki T Sawada K Koike T

Cytotherapy, Vol. 6, Iss. 4, 2004-08 ,pp. : 337-343

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Prediction of CD34 ⁺⁺ cell yield in hematopoietic cell products from children by peripheral blood CD34 ⁺⁺ cell counts

By Rujkijyanont Piya Hipps John Gan Kwan Yang Jie Wang Chong Geiger Terrence L. Eldridge Paul W. Leung Wing

Cytotherapy, Vol. 14, Iss. 4, 2012-04 ,pp. : 473-482

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Accurate calculation of blood volume to be processed by apheresis to achieve target CD34⁺ cell numbers for PBPC transplantation

By Trickett A E Smith S Kwan Y L

Cytotherapy, Vol. 3, Iss. 1, 2001-01 ,pp. : 5-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite